Anika Therapeutics, Inc. (ANIK) Share buybacks
- Total buybacks · last 12 months (USD): Value $15.06M; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $15.06M | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 15.06M USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $15.06M | (m) | (m) |
| 2026-03-31 | $14.20M | (m) | (m) |
| 2025-12-31 | $9.48M | (m) | (m) |
| 2025-09-30 | $9.55M | (m) | (m) |
| 2025-06-30 | $13.52M | (m) | (m) |
| 2025-03-31 | $14.88M | (m) | (m) |
| 2024-12-31 | $10.91M | (m) | (m) |
| 2024-09-30 | $5.34M | (m) | (m) |
| 2024-06-30 | $1.37M | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) |
| 2023-12-31 | $5.00M | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | (m) | (m) |
| 2020-12-31 | $0.00 | (m) | (m) |
| 2020-09-30 | $0.00 | (m) | (m) |
| 2020-06-30 | $0.00 | (m) | (m) |
| 2019-12-31 | $30.00M | (m) | (m) |
| 2019-09-30 | $30.00M | (m) | (m) |
| 2019-06-30 | $30.00M | (m) | (m) |
| 2018-12-31 | $30.00M | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) |
| 2017-09-30 | $0.00 | (m) | (m) |
| 2017-06-30 | $0.00 | (m) | (m) |
| 2016-12-31 | $25.00M | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |